The "Elevate" by MAPS Podcast

The podcast objectives are to : explain what publication plain-language summaries are and how patients find them useful share patient experience of being involved in reviewing PLS, and key points to consider from a patient’s perspective when developing PLS  Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development, CMC Affinity, a McCann Health CompanyInterviewee: Simon R. Stones BSc (Hons) MMRS, Health Advocate and Consultant, Collaboro Consulting

At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partnersModerator: Kathryn Gann, Independent ConsultantInterviewer: Ralph Rewers, National MSL Director, Anti-Infectives/HCV/Virology, AbbVieGuest: Shontelle Dodson, PharmD, Sr. VP of Health Systems, Astellas Pharmaceuticals

In this second of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs. 

The podcast objectives are to : explain what publication plain-language summaries are and their value share Pharma experience of developing PLS, including how to overcome any Pharma specific challenges  Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development CMC Affinity, a McCann Health companyInterviewee: Dheepa Chari, Head, Global Scientific Publications, Pfizer Oncology,

MAPS speaks with Kent Summers, HEOR Lead at AlphaGroup and Steve Camper, VP of Medical Affairs at Blue Earth Diagnostics, about building Health Economics and Outcomes Research capabilities within Medical Affairs.

Objectives: At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partners

This episode of the MAPS podcast series, Elevate, explores the differing approaches applied in the pharmaceutical and device industries to understand the impact and approach to acquired and internally generated data, analytics, and insights play in delivering value.  

The Series Podcast Objectives are:  Understand how the medical affairs strategic planning process can drive decision making throughout the year  Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed  Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts  Moderator: Monica DeAbadal, MD, MBA/HSA,VP, Medical Excellence, Ipsen Speaker: Peter Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare Speaker: Eileen K Sawyer PhD, Vice-President, Global Medical Affairs, UniQure , Speaker: Len Valentino, MD, President and CEO, National Hemophilia FoundationSpeaker: Anna Walz, CEO, MedEvoke

Even before the COVID-19 pandemic, the structure and content of interactions between MSLs and KOLs/HCPs was shifting, with MSLs increasingly seen as trusted partners in scientific exchange and KOLs/HCPs increasingly open to technology-based communications. Of course, the pandemic has accelerated this change, shifting the mechanics of communication and collaboration and throwing into focus the definition of “value.” This podcast presents the expertise of leaders from pharmaceutical organizations Pfizer and Nektar, as well as Larvol, focusing on how MSLs bring value to HCPs and KOLs during the time of pandemic.Speakers: ·      Tim Hylan, VP, Internal Medicine Field Medical Director Group at Pfizer·      Sue Currie, VP, Head of Medical Affairs at Nektar Therapeutics·      Bruno Larvol, Founder and CEO at Larvol

The Series Podcast Objectives are:  Understand how the medical affairs strategic planning process can drive decision making throughout the year  Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed  Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts  Moderator: Monica DeAbadal, MD, MBA/HSA,VP, Medical Excellence, Ipsen Speaker: Peter Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer HealthcareSpeaker: Eileen K Sawyer PhD, Vice-President, Global Medical Affairs, UniQureSpeaker: Len Valentino, MD, President and CEO, National Hemophilia FoundationSpeaker: Anna Walz, CEO, MedEvoke